Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T13491 | ||||
Target Name | Solute carrier family 29 member 1 (SLC29A1) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | 6-(4-Nitro-benzylsulfanyl)-9-phenethyl-9H-purine | Drug Info | Ki = 2200 nM | [1] | |
9-Benzyl-6-(4-nitro-benzylsulfanyl)-9H-purine | Drug Info | Ki = 135 nM | [1] | ||
LIDOFLAZINE | Drug Info | Ki = 279.9 nM | [3] | ||
N6-CYCLOPENTYLADENOSINE | Drug Info | Ki = 1100 nM | [2] | ||
S6-nitrobenzyl mercaptopurine riboside | Drug Info | Ki = 0.7 nM | [4] | ||
References | |||||
REF 1 | Inhibition of nucleoside transport by new analogues of 4-nitrobenzylthioinosine: replacement of the ribose moiety by substituted benzyl groups. J Med Chem. 2004 Oct 21;47(22):5441-50. | ||||
REF 2 | Inhibition of nucleoside transport proteins by C8-alkylamine-substituted purines. J Med Chem. 2005 Jan 13;48(1):321-9. | ||||
REF 3 | Synthesis, flow cytometric evaluation, and identification of highly potent dipyridamole analogues as equilibrative nucleoside transporter 1 inhibit... J Med Chem. 2007 Aug 9;50(16):3906-20. | ||||
REF 4 | Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors. Bioorg Med Chem Lett. 2009 Feb 1;19(3):917-21. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.